AMLX Amylyx Pharmaceuticals, Inc. logo

AMLX Amylyx Pharmaceuticals, Inc.

Healthcare
$13.58-2.51%ClosedMarket Cap: $1.13B

As of 2026-05-25

Insider Statistics (Q1 2026)

Acquisitions

4

Dispositions

22

Buy/Sell Ratio

0.18

Net Shares

-434,093

Shares Acquired

400,000

Shares Disposed

834,093

Total Bought ($)

$0.00

Total Sold ($)

$17.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Mon Mar 09Mazzariello Ginaofficer: Chief Legal OfficerSell111,990$14.10111,990
Mon Mar 09Mazzariello Ginaofficer: Chief Legal OfficerSell74,660$0.00209,090
Mon Mar 09Klee Justin B.director, officer: Co-Chief Executive OfficerSell373,295$14.10373,295
Mon Mar 09Klee Justin B.director, officer: Co-Chief Executive OfficerSell248,865$0.003,583,481
Mon Mar 09FRATES JAMES Mofficer: Chief Financial OfficerSell143,985$14.10143,985
Mon Mar 09FRATES JAMES Mofficer: Chief Financial OfficerSell95,990$0.00261,628
Mon Mar 09Cohen Joshua Bdirector, officer: Co-Chief Executive OfficerSell373,295$14.10373,295
Mon Mar 09Cohen Joshua Bdirector, officer: Co-Chief Executive OfficerSell248,865$0.003,583,548
Mon Mar 09Bedrosian Camille Lofficer: Chief Medical OfficerSell143,985$14.10143,985
Mon Mar 09Bedrosian Camille Lofficer: Chief Medical OfficerSell95,990$0.00265,285